1. Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study 
I. Möller, M. Pérez, J. Monfort, P. Benito, J. Cuevas, C. Perna, G. Doménech, M. Herrero, E. Montell, J. Vergés 
Osteoarthritis and Cartilage 
Volume 18, Pages S32-S40 (June 2010)
DOI: /j.joca
Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions

2. Fig. 1 Flow-chart of the distribution of study patients.
Osteoarthritis and Cartilage  , S32-S40DOI: ( /j.joca )
Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions

3. Fig. 2
Average change from baseline of VAS scores during treatment with CS or PBO. Significant differences at 1 month (∗P<0.05) and at the end of the study (3 months) (∗∗P<0.01).
Osteoarthritis and Cartilage  , S32-S40DOI: ( /j.joca )
Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions

4. Fig. 3
Average changes of Lequesne score during treatment with CS or PBO. Significant differences at the end of the study (3 months) (∗P<0.05).
Osteoarthritis and Cartilage  , S32-S40DOI: ( /j.joca )
Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions

5. Fig. 4
(A) Percentage of patients with plantar psoriasis during treatment with CS or PBO. Significant differences at the end of the study (3 months) (∗P<0.05). (B) Reduction of plantar psoriasis intensity over the 12-week treatment period with CS 800mg/day. (i) Before treatment, (ii) After treatment.
Osteoarthritis and Cartilage  , S32-S40DOI: ( /j.joca )
Copyright © 2010 Osteoarthritis Research Society International Terms and Conditions